BioMarin Pharmaceutical's GAAP net income for 2022 was $149.56 million, against a loss of $82.34 million in the previous year. Revenue increased 13.5% to $2.096 billion from $1.846 billion a year earlier.
BioMarin Pharmaceutical's GAAP net income for 2022 was $149.56 million, against a loss of $82.34 million in the previous year. Revenue increased 13.5% to $2.096 billion from $1.846 billion a year earlier. 
investors.biomarin.com
English (US) 